Hansa Biopharma AB
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-07-22
Analyst
Van Lenschot-Kepen
Equibles does not estimate personal net worth.
Suzanne Van Viertheisen is recorded as Analyst at Van Lenschot-Kepen. Suzanne Van Viertheisen has spoken on 1 earnings call across 1 company, most recently for Hansa Biopharma AB on July 22, 2026. The companies whose calls Suzanne Van Viertheisen spoke on are classified in the Healthcare sector.
“So you've indicated that you're in discussions with the FDA for 5487. To clarify, what are still some outstanding topics or next steps before reaching an agreement? and is there anything you could potentially share on any preliminary design?”
Van Lenschot-Kepen
Analyst
Transcript header (unverified)
Hansa Biopharma AB
Biotechnology · Healthcare
Interim Report January-June 2026 Conference Call
Hansa Biopharma AB